| NCT ID | NCT05883995 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospices Civils de Lyon |
| Condition | Bone Infection |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2023-02-01 |
| Primary Completion | 2028-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2023-02-01 with a primary completion date of 2028-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Avis-PHAGEinLYON Clinic study is a single site non-interventional retrospective and prospective study, initiated by the Hospices Civils de Lyon. Population targeted are patients referred to the Hospices Civils de Lyon for a medical advice for a phage therapy from 2015 to 2028. The primary objective is to quantify the phage therapy requests received at the Hospices Civils de Lyon. 1500 patients will be included in the study.
Eligibility Criteria
Inclusion Criteria: * \- Patient referred to the Hospices Civils de Lyon for a phage therapy request from 01/01/2015 to 01/01/2028. * Avis-PHAGEinLYON clinic study information notice provided to the patient Exclusion Criteria: * \- Opposition of trial participant
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05883995 clinical trial?
This trial is open to participants of all sexes, studying Bone Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05883995 currently recruiting?
Yes, NCT05883995 is actively recruiting participants. Contact the research team at Tristan.ferry@chu-lyon.fr for enrollment information.
Where is the NCT05883995 trial being conducted?
This trial is being conducted at Lyon, France.
Who is sponsoring the NCT05883995 clinical trial?
NCT05883995 is sponsored by Hospices Civils de Lyon. The trial plans to enroll 1,500 participants.